Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Curcumin is a polyphenolic compound derived from the spice turmeric (Curcuma longa). It is not a classical therapeutic target, but a small molecule that exerts pleiotropic anti-inflammatory effects by modulating multiple molecular signaling pathways including the inhibition of nuclear factor kappa-B (NF-κB), mitogen-activated protein kinases (MAPK), the Janus kinase-signal transducer and activator of transcription pathway (JAK-STAT), and the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome[1][2][3][4]. Curcumin also inhibits enzymes like cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), reduces pro-inflammatory cytokine production, and displays antioxidant activity[3][6][7]. As such, "Turmeric anti-inflammatory action" does not correspond to a singular protein or defined target but describes the broad pharmacological actions of curcumin.
Inhibition of NF-κB pathway, Inhibition of MAPK/ERK pathway, Inhibition/modulation of JAK-STAT signaling, Suppression of COX-2 and iNOS expression, Direct scavenging of reactive oxygen species, Modulation of NLRP3 inflammasome activation, Ligand/modulator of PPAR-γ[1][2][3][4][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Turmeric anti-inflammatory action.